<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M842</article-id>
      <article-id pub-id-type="publisher-id">molbank-2015-M842</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>6-(4-Amino-1-methyl-2-(methylthio)-6-oxo-1,6-dihydro-pyrimidin-5-yl)-3,6-dimethyl-2-(methylthio)-6,7-dihydro-3<italic>H</italic>-pyrrolo[2,3-<italic>d</italic>]pyrimidine-4,5-dione</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Romo</surname>
            <given-names>Pablo E.</given-names>
          </name>
          <xref rid="af1-molbank-2015-M842" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quiroga</surname>
            <given-names>Jairo</given-names>
          </name>
          <xref rid="af1-molbank-2015-M842" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2015-M842" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Insuasty</surname>
            <given-names>Braulio</given-names>
          </name>
          <xref rid="af1-molbank-2015-M842" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nogueras</surname>
            <given-names>Manuel</given-names>
          </name>
          <xref rid="af2-molbank-2015-M842" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cobo</surname>
            <given-names>Justo</given-names>
          </name>
          <xref rid="af2-molbank-2015-M842" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2015-M842"><label>1</label>Heterocyclic Compound Research Group, Department of Chemistry, Universidad del Valle, A.A. 25360 Cali, Colombia; E-Mails: <email>pabloromo13@gmail.com</email> (P.E.R.); <email>braulio.insuasty@correounivalle.edu.co</email> (B.I.)</aff>
      <aff id="af2-molbank-2015-M842"><label>2</label>Department of Inorganic and Organic Chemistry, Universidad de Ja&#xE9;n, 23071 Ja&#xE9;n, Spain; E-Mails: <email>mmontiel@ujaen.es</email> (M.N.); <email>jcobo@ujaen.es</email> (J.C.)</aff>
      <author-notes>
        <corresp id="c1-molbank-2015-M842"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>jairo.quiroga@correounivalle.edu.co</email>; Tel.: +57-2-3393248; Fax: +57-2-3392444.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>02</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>03</month>
        <year>2015</year>
      </pub-date>
      <volume>2015</volume>
      <issue>1</issue>
      <elocation-id>M842</elocation-id>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>01</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The title compound 6-(4-amino-1-methyl-2-(methylthio)-6-oxo-1,6-dihydro-pyrimidin-5-yl)-3,6-dimethyl-2-(methylthio)-6,7-dihydro-3<italic>H</italic>-pyrrolo[2,3-<italic>d</italic>]pyrimidine-4,5-dione was synthesized in 60% yield by a microwave-induced cyclocondensation reaction of aminopyrimidine with pyruvic acid in the presence of cerium ammonium nitrate (CAN) as catalyst.</p>
      </abstract>
      <kwd-group>
        <kwd>pyrrolo[2,3-<italic>d</italic>]pyrimidine</kwd>
        <kwd>microwave irradiation</kwd>
        <kwd>cerium ammonium nitrate</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Nitrogen heterocycles have received a great deal of attention in the literature as a result of their role as pharmacophores of great historical significance. Among these heterocyclic systems, those containing pyrimidine in particular have been the subject of expanding research efforts in heteroaromatic and biological chemistry.</p>
      <p>The structural diversity and biological importance of pyrimidines have made them attractive synthesis targets for many years. The pyrimidine is a widespread heterocyclic moiety, present in numerous natural products as well as synthetic pharmacophores with biological activities [<xref ref-type="bibr" rid="B1-molbank-2015-M842">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2015-M842">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2015-M842">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2015-M842">4</xref>]. Substituted pyrimidines, particularly with amino groups at the 2 and 4 positions, are known pharmacophores in several structure-based drug design approaches in medicinal chemistry [<xref ref-type="bibr" rid="B5-molbank-2015-M842">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2015-M842">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2015-M842">7</xref>]. Pyrimidines and their fused derivatives have been studied continuously because they exhibit broad biological activity as antitumor [<xref ref-type="bibr" rid="B8-molbank-2015-M842">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2015-M842">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2015-M842">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2015-M842">11</xref>], antifungal [<xref ref-type="bibr" rid="B12-molbank-2015-M842">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2015-M842">13</xref>], antibacterial [<xref ref-type="bibr" rid="B12-molbank-2015-M842">12</xref>,<xref ref-type="bibr" rid="B14-molbank-2015-M842">14</xref>,<xref ref-type="bibr" rid="B15-molbank-2015-M842">15</xref>,<xref ref-type="bibr" rid="B16-molbank-2015-M842">16</xref>], anti-HIV agents [<xref ref-type="bibr" rid="B17-molbank-2015-M842">17</xref>,<xref ref-type="bibr" rid="B18-molbank-2015-M842">18</xref>,<xref ref-type="bibr" rid="B19-molbank-2015-M842">19</xref>]. The synthesis of pyrrolopyrimidines is of high interest in medicinal chemistry, because some of them possess biological and pharmacological activities, such as anti-leukemia [<xref ref-type="bibr" rid="B20-molbank-2015-M842">20</xref>], tyrosine kinase inhibitors [<xref ref-type="bibr" rid="B20-molbank-2015-M842">20</xref>,<xref ref-type="bibr" rid="B21-molbank-2015-M842">21</xref>,<xref ref-type="bibr" rid="B22-molbank-2015-M842">22</xref>,<xref ref-type="bibr" rid="B23-molbank-2015-M842">23</xref>], anti-HIV-1 [<xref ref-type="bibr" rid="B24-molbank-2015-M842">24</xref>], antibiotic [<xref ref-type="bibr" rid="B25-molbank-2015-M842">25</xref>], antiangiogenic and antitumor properties [<xref ref-type="bibr" rid="B20-molbank-2015-M842">20</xref>]. Syntheses of pyrrolopyrimidines have been reported by several authors. Generally an aminopyrimidine reacts with either an &#x3B1;-halo-aldehyde [<xref ref-type="bibr" rid="B26-molbank-2015-M842">26</xref>,<xref ref-type="bibr" rid="B27-molbank-2015-M842">27</xref>], &#x3B1;-halo-ketone [<xref ref-type="bibr" rid="B28-molbank-2015-M842">28</xref>,<xref ref-type="bibr" rid="B29-molbank-2015-M842">29</xref>] or &#x3B1;-halo-acid chloride [<xref ref-type="bibr" rid="B29-molbank-2015-M842">29</xref>].</p>
      <p>In continuation of our previous studies of the synthesis of heterocyclic compounds from heterocyclic amines [<xref ref-type="bibr" rid="B30-molbank-2015-M842">30</xref>,<xref ref-type="bibr" rid="B31-molbank-2015-M842">31</xref>,<xref ref-type="bibr" rid="B32-molbank-2015-M842">32</xref>,<xref ref-type="bibr" rid="B33-molbank-2015-M842">33</xref>,<xref ref-type="bibr" rid="B34-molbank-2015-M842">34</xref>,<xref ref-type="bibr" rid="B35-molbank-2015-M842">35</xref>,<xref ref-type="bibr" rid="B36-molbank-2015-M842">36</xref>], in this work a novel pyrrolo[2,3-<italic>d</italic>]pyrimidine synthesis was performed, where the target compound was obtained by the reaction between the aminopyrimidine and pyruvic acid (an &#x3B1;-keto-acid) using a microwave irradiation and cerium ammonium nitrate (CAN) as catalyst.</p>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>The synthesis of 6-(4-amino-1-methyl-2-(methylthio)-6-oxo-1,6-dihydropyrimidin-5-yl)-3,6-dimethyl-2-(methylthio)-6,7-dihydro-3<italic>H</italic>-pyrrolo[2,3-<italic>d</italic>]pyrimidine-4,5-dione involves the reaction of aminopyrimidine <bold>1</bold> (2 eq.) with pyruvic acid (<bold>2</bold>, 1 eq.) in ethanol (<xref ref-type="scheme" rid="molbank-2015-M842-sch001">Scheme 1</xref>). The reaction mixture was irradiated with microwaves at 80 &#xB0;C for 8 minutes; cerium ammonium nitrate (CAN) was used as the catalyst. The reaction was monitored using thin layer chromatography. The yellow cream solid formed was filtered under reduced pressure and did not require further purification.</p>
      <p>The structure of the compound <bold>3</bold> was determined by spectroscopic techniques and mass spectrometry. The proton NMR spectrum showed signals for nonequivalent SCH<sub>3</sub> and NCH<sub>3</sub> groups at 2.54, 2.60, 3.20 and 3.39 ppm as a singlets, respectively, whereas a singlet at &#x3B4; 1.55 ppm was assigned to the 6-CH<sub>3</sub> protons and two singlets at 6.45 and 10.83 ppm correspond to the NH<sub>2</sub> group and NH of the pyrrole ring. The IR spectrum analysis showed the NH band at 3402 and 3329 cm<sup>&#x2212;1</sup>, and carbonyl bands at 1751 and 1632 cm<sup>&#x2212;1</sup>.</p>
      <p>A plausible mechanism is shown in <xref ref-type="scheme" rid="molbank-2015-M842-sch002">Scheme 2</xref>. Initially the CAN, dissociates into its constituents. It is known that the nitrate anion and the ammonium cation can react to form nitric acid and ammonia. The Ce(IV) is coordinated with the carbonyl groups [<xref ref-type="bibr" rid="B37-molbank-2015-M842">37</xref>] of pyruvic acid, and the C-5 carbon of the aminopyrimidine performs a nucleophilic attack on the carbonyl group of the carboxylic acid to form intermediate <bold>Ia</bold>, which loses water and forms <bold>Ib</bold>. Compound <bold>Ib</bold> subsequently reacts with another mole of aminopyrimidine to form <bold>IIa-b</bold>, and the acidic medium promotes the decoupling of the Ce(IV) from the carbonyl groups and allows a second dehydration, followed by the cyclization of the second amino group to form the desired pyrrolo[2,3-<italic>d</italic>]pyrimidine <bold>3</bold>.</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General Information</title>
        <p>The reaction progress was monitored by precoated TLC plates of silica gel 60GF254 of 0.2 &#xB5;m thickness (Merck, Darmstadt, Germany). Melting points were measured using a Stuart SMP3 melting point apparatus and are uncorrected. IR spectra were obtained with an IR Affinity-1 instrument (Shimadzu, Kyoto, Japan) equipped with an ATR accessory. The <sup>1</sup>H and <sup>13</sup>C-NMR spectra were run on a DPX 400 spectrometer (Bruker, Bruker BioSpin GmbH, Rheinstetten, Germany) operating at 400 and 101 MHz respectively, using dimethyl sulfoxide-<italic>d</italic><sub>6</sub> as solvent and TMS as internal standard. The mass spectrum was obtained on a Shimadzu-GCMS-QP2010 spectrometer operating at 70 eV. Microwave experiments were carried out in a CEM Discover System<sup>TM</sup> 300 W focused microwave reactor (manufacturer, Charlotte, NC, USA).</p>
      </sec>
      <sec>
        <title>Procedure for the Synthesis of 6-(4-Amino-1-methyl-2-(methylthio)-6-oxo-1,6-dihydropyrimidin-5-yl)-3,6-dimethyl-2-(methylthio)-6,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-4,5-dione</title>
        <p>A mixture of 6-aminopyrimidine <bold>1</bold> (2 mmol) and pyruvic acid (<bold>2</bold>, 1 mmol) and CAN 10% mol in ethanol (1 mL) was heated by microwave irradiation for 8 minutes (80 &#xB0;C). The solid was filtered under reduced pressure and washed with ethanol. Compound <bold>3</bold> was obtained in high purity (according to TLC and the corresponding NMR spectrum) and did not require further recrystallization. Yellow cream solid, Yield: 60% M.p.: 254 &#xB0;C (dec). IR (ATR) (cm<sup>&#x2212;1</sup>): 3402 (NH), 3329 (NH), 3217 (C-H), 1751 (C=O), 1632 (C=O). <sup>1</sup>H-NMR (DMSO-<italic>d</italic><sub>6</sub>) &#x3B4; ppm: 1.55 (s, 3H, C<underline>H<sub>3</sub></underline>), 2.54 (s, 3H, SC<underline>H<sub>3</sub></underline>), 2.60 (s, 3H, SC<underline>H<sub>3</sub></underline>), 3.20 (s, 3H, N-C<underline>H<sub>3</sub></underline>), 3.39 (s, 3H, N-C<underline>H<sub>3</sub></underline>), 6.45 (s, 2H, N<underline>H<sub>2</sub></underline>), 10.83 (s, 1H, N<underline>H</underline>). <sup>13</sup>C-NMR (DMSO-<italic>d</italic><sub>6</sub>) &#x3B4; ppm: 14.5 (SCH<sub>3</sub>), 15.2 (SCH<sub>3</sub>), 20.2 (CH<sub>3</sub>), 29.9 (N-CH<sub>3</sub>), 30.2 (N-CH<sub>3</sub>), 47.2 (C), 94.4 (C), 101.6 (C), 157.9 (C), 158.9 (C), 159.9 (C), 160.9 (C), 165.0 (C), 181.9 (C). MS (EI): <italic>m/z</italic> 394 (57, [M<sup>+</sup>]), 379 (77, M<sup>+</sup> - CH<sub>3</sub>). Anal. Calcd. For C<sub>15</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub>S<sub>2</sub> (394.47): C: 45.67; H: 4.60; N: 21.31; Found: C: 45.51; H: 4.49; N: 21.44.</p>
      </sec>
      </sec>
  </body>
  <back>
<app-group>
    <app id="app1-molbank-2015-M842">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2015-M842-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M842-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2015-M842-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M842-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>Authors wish to thank the COLCIENCIAS and Universidad del Valle for financial support.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>The authors PER, JQ, BI, MN and JC designed and accomplished research. Also, they analyzed data and wrote the paper together. Finally, all authors read and approved the final manuscript.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2015-M842">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choudhury</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nilsen</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Sorgi</surname>
              <given-names>K.L.</given-names>
            </name>
          </person-group>
          <article-title>A chemoselective aniline&#x2013;chloropyrimidine coupling in a competing electrophilic environment</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2008</year>
          <volume>49</volume>
          <fpage>102</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2007.11.009</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2015-M842">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Br&#xE6;ndvang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gundersen</surname>
              <given-names>L.-L.</given-names>
            </name>
          </person-group>
          <article-title>Efficient and regioselective N-1 alkylation of 4-chloropyrazolo[3,4-<italic>d</italic>]pyrimidine</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>3057</fpage>
          <lpage>3059</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2007.02.116</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2015-M842">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Journet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Humphrey</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>A Highly Regioselective Amination of 6-Aryl-2,4-dichloropyrimidine</article-title>
          <source>Org. Lett.</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>395</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="doi">10.1021/ol052578p</pub-id>
          <pub-id pub-id-type="pmid">16435843</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2015-M842">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Girreser</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Heber</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Sch&#xFC;tt</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of 6-substituted 7-aryl-5,6-dihydropyrido[2,3-<italic>d</italic>]pyrimidine(1<italic>H</italic>,3<italic>H</italic>)-2,4-diones using the Vilsmeier reaction</article-title>
          <source>Tetrahedron</source>
          <year>2004</year>
          <volume>60</volume>
          <fpage>11511</fpage>
          <lpage>11517</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tet.2004.09.075</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2015-M842">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boudet</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Knochel</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Chemo- and regioselective functionalization of uracil derivatives. Applications to the synthesis of oxypurinol and emivirine</article-title>
          <source>Org. Lett.</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>3737</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1021/ol061295+</pub-id>
          <pub-id pub-id-type="pmid">16898805</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2015-M842">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baraldi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bovero</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fruttarolo</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Romagnoli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Aghzadeh</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Preti</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Varani</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Borea</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Moorman</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>New strategies for the synthesis of A<sup>3</sup> adenosine receptor antagonists</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2003</year>
          <volume>11</volume>
          <fpage>4161</fpage>
          <lpage>4169</lpage>
          <pub-id pub-id-type="doi">10.1016/S0968-0896(03)00484-X</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2015-M842">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baraldi</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Cacciari</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Romagnoli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Spalluto</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Moro</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Klotz</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Varani</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gessi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Merighi</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective Human A<sup>3</sup> Adenosine Receptor Antagonists: Influence of the Chain at the N<sup>8</sup> Pyrazole Nitrogen</article-title>
          <source>J. Med. Chem.</source>
          <year>2000</year>
          <volume>43</volume>
          <fpage>4768</fpage>
          <lpage>4780</lpage>
          <pub-id pub-id-type="doi">10.1021/jm001047y</pub-id>
          <pub-id pub-id-type="pmid">11123985</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2015-M842">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Sayed</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>El-Bendary</surname>
              <given-names>E.R.</given-names>
            </name>
            <name>
              <surname>El-Ashry</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>El-Kerdawy</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-<italic>a</italic>]pyrimidines</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2011</year>
          <volume>46</volume>
          <fpage>3714</fpage>
          <lpage>3720</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.05.037</pub-id>
          <pub-id pub-id-type="pmid">21705114</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2015-M842">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fares</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Abou-Seri</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Abdel-Aziz</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Abbas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Youssef</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Eladwy</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antitumor activity of pyrido [2,3-<italic>d</italic>]pyrimidine and pyrido[2,3-<italic>d</italic>][1,2,4]triazolo[4,3-<italic>a</italic>]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2014</year>
          <volume>83</volume>
          <fpage>155</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.06.027</pub-id>
          <pub-id pub-id-type="pmid">24956552</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2015-M842">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Omary</surname>
              <given-names>F.A.M.</given-names>
            </name>
            <name>
              <surname>Hassan</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>El-Messery</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>El-Subbagh</surname>
              <given-names>H.I.</given-names>
            </name>
          </person-group>
          <article-title>Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-<italic>b</italic>]quinazoline and pyrido[4,3-<italic>d</italic>]thiazolo[3,2-<italic>a</italic>]pyrimidine analogues</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2012</year>
          <volume>47</volume>
          <fpage>65</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.10.023</pub-id>
          <pub-id pub-id-type="pmid">22056277</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2015-M842">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Design, synthesis and biological evaluation of novel thieno[3,2-<italic>d</italic>]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2014</year>
          <volume>87</volume>
          <fpage>782</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.10.022</pub-id>
          <pub-id pub-id-type="pmid">25440879</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2015-M842">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hilmy</surname>
              <given-names>K.M.H.</given-names>
            </name>
            <name>
              <surname>Khalifa</surname>
              <given-names>M.M.A.</given-names>
            </name>
            <name>
              <surname>Hawata</surname>
              <given-names>M.A.A.</given-names>
            </name>
            <name>
              <surname>Keshk</surname>
              <given-names>R.M.A.</given-names>
            </name>
            <name>
              <surname>El-Torgman</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of new pyrrolo[2,3-<italic>d</italic>]pyrimidine derivatives as antibacterial and antifungal agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2010</year>
          <volume>45</volume>
          <fpage>5243</fpage>
          <lpage>5250</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2010.08.043</pub-id>
          <pub-id pub-id-type="pmid">20828885</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2015-M842">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gholap</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Toti</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Shirazi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Deshpande</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>K.V.</given-names>
            </name>
          </person-group>
          <article-title>Efficient synthesis of antifungal pyrimidines via palladium catalyzed Suzuki/Sonogashira cross-coupling reaction from Biginelli 3,4-dihydropyrimidin-2(1<italic>H</italic>)-ones</article-title>
          <source>Tetrahedron</source>
          <year>2008</year>
          <volume>64</volume>
          <fpage>10214</fpage>
          <lpage>10223</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tet.2008.08.033</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2015-M842">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhalgat</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Ramesh</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, antimicrobial screening and structure&#x2013;activity relationship of novel pyrimidines and their thioethers</article-title>
          <source>Bull. Fac. Pharmacy, Cairo Univ.</source>
          <year>2014</year>
          <volume>52</volume>
          <fpage>259</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bfopcu.2014.08.001</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2015-M842">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saikia</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Bharali</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Thakur</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>A convenient synthesis of novel 5-aryl-pyrido[2,3-<italic>d</italic>]pyrimidines and screening of their preliminary antibacterial properties</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2014</year>
          <volume>55</volume>
          <fpage>1796</fpage>
          <lpage>1801</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2014.01.128</pub-id>
        </citation>
      </ref>
      <ref id="B16-molbank-2015-M842">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Adiwish</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Tahir</surname>
              <given-names>M.I.M.</given-names>
            </name>
            <name>
              <surname>Siti-Noor-Adnalizawati</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hashim</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Ibrahim</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yaacob</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, antibacterial activity and cytotoxicity of new fused pyrazolo[1,5-<italic>a</italic>]pyrimidine and pyrazolo[5,1-<italic>c</italic>][1,2,4]triazine derivatives from new 5-aminopyrazoles</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2013</year>
          <volume>64</volume>
          <fpage>464</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2013.04.029</pub-id>
          <pub-id pub-id-type="pmid">23669354</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2015-M842">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallis</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Mahmood</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Fraser</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides</article-title>
          <source>Il Farmaco</source>
          <year>1999</year>
          <volume>54</volume>
          <fpage>83</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-827X(98)00107-4</pub-id>
        </citation>
      </ref>
      <ref id="B18-molbank-2015-M842">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gazivoda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Rai&#x107;-Mali&#x107;</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kristafor</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Makuc</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Plavec</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bratuli&#x107;</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kraljevi&#x107;-Paveli&#x107;</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Paveli&#x107;</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Naesens</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Andrei</surname>
              <given-names>G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2008</year>
          <volume>16</volume>
          <fpage>5624</fpage>
          <lpage>5634</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2008.03.074</pub-id>
          <pub-id pub-id-type="pmid">18424155</pub-id>
        </citation>
      </ref>
      <ref id="B19-molbank-2015-M842">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Rai</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>de Clercq</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Pannecouque</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-<italic>a</italic>]pyrimidine derivatives</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2014</year>
          <volume>22</volume>
          <fpage>2052</fpage>
          <lpage>2059</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2014.02.029</pub-id>
          <pub-id pub-id-type="pmid">24631361</pub-id>
        </citation>
      </ref>
      <ref id="B20-molbank-2015-M842">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gangjee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Namjoshi</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ihnat</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Thorpe</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Bailey-Downs</surname>
              <given-names>L.C.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic><sup>2</sup>-Trimethylacetyl substituted and unsubstituted-<italic>N</italic><sup>4</sup>-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7<italic>H</italic>-pyrrolo[2,3-<italic>d</italic>]pyrimidine-2,4-diamines: Design, cellular receptor tyrosine kinase inhibitory activities and <italic>in vivo</italic> evaluation as antiangiogenic, antimetastatic and antitumor agents</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2013</year>
          <volume>21</volume>
          <fpage>1312</fpage>
          <lpage>1323</lpage>
          <pub-id pub-id-type="pmid">23375090</pub-id>
        </citation>
      </ref>
      <ref id="B21-molbank-2015-M842">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gangjee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zaware</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Raghavan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Thorpe</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Ihnat</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic><sup>4</sup>-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-<italic>d</italic>]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: Design, synthesis, and <italic>in vivo</italic> evaluation</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2012</year>
          <volume>20</volume>
          <fpage>2444</fpage>
          <lpage>2454</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2012.01.029</pub-id>
          <pub-id pub-id-type="pmid">22370340</pub-id>
        </citation>
      </ref>
      <ref id="B22-molbank-2015-M842">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chamberlain</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Deanda</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Patnaik</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Redman</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Shewchuk</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sabbatini</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Leesnitzer</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Groy</surname>
              <given-names>A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discovery of 4,6-bis-anilino-1<italic>H</italic>-pyrrolo[2,3-<italic>d</italic>]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>469</fpage>
          <lpage>473</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2008.11.046</pub-id>
          <pub-id pub-id-type="pmid">19056263</pub-id>
        </citation>
      </ref>
      <ref id="B23-molbank-2015-M842">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaspersen</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>S&#xF8;rum</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Willassen</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Fuglseth</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kj&#xF8;bli</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bj&#xF8;rk&#xF8;y</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sundby</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hoff</surname>
              <given-names>B.H.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and <italic>in vitro</italic> EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-<italic>N</italic>-substituted 6-aryl-7<italic>H</italic>-pyrrolo[2,3-<italic>d</italic>]pyrimidine-4-amines</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2011</year>
          <volume>46</volume>
          <fpage>6002</fpage>
          <lpage>6014</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.10.012</pub-id>
          <pub-id pub-id-type="pmid">22018877</pub-id>
        </citation>
      </ref>
      <ref id="B24-molbank-2015-M842">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ge</surname>
              <given-names>Z.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synthesis and anti-HIV-1 activity of 4-substituted-7-(2'-deoxy-2'-fluoro-4'-azido-&#x3B2;-<sc>d</sc>-ribofuranosyl)pyrrolo[2,3-<italic>d</italic>]pyrimidine analogues</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>6770</fpage>
          <lpage>6772</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2011.09.040</pub-id>
          <pub-id pub-id-type="pmid">21974951</pub-id>
        </citation>
      </ref>
      <ref id="B25-molbank-2015-M842">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Gangjee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>K.S.</given-names>
            </name>
          </person-group>
          <article-title>Substituted pyrrolo[2,3-<italic>d</italic>]pyrimidines as Cryptosporidium hominis thymidylate synthase inhibitors</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2013</year>
          <volume>23</volume>
          <fpage>5426</fpage>
          <lpage>5428</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2013.07.037</pub-id>
          <pub-id pub-id-type="pmid">23927969</pub-id>
        </citation>
      </ref>
      <ref id="B26-molbank-2015-M842">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Acosta</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Cruz</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Abon&#xED;a</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Generation of pyrrolo[2,3-<italic>d</italic>]pyrimidines. Unexpected products in the multicomponent reaction of 6-aminopyrimidines, dimedone, and arylglyoxal</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>5443</fpage>
          <lpage>5447</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2010.08.021</pub-id>
        </citation>
      </ref>
      <ref id="B27-molbank-2015-M842">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnett</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Grubb</surname>
              <given-names>L.M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of pyrrolo[2,3-<italic>d</italic>]pyrimidines via cyclocondensation of &#x3B2;-alkoxy and &#x3B2;-amino-&#x3B1;-bromoaldehydes</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>9741</fpage>
          <lpage>9745</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4039(00)01768-8</pub-id>
        </citation>
      </ref>
      <ref id="B28-molbank-2015-M842">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bundy</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Ayer</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Banitt</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Belonga</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Mizsak</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Tustin</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Linseman</surname>
              <given-names>K.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synthesis of Novel 2,4-Diaminopyrrolo-[2,3-<italic>d</italic>]pyrimidines with Antioxidant, Neuroprotective, and Antiasthma Activity</article-title>
          <source>J. Med. Chem.</source>
          <year>1995</year>
          <volume>38</volume>
          <fpage>4161</fpage>
          <lpage>4163</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00021a004</pub-id>
          <pub-id pub-id-type="pmid">7473542</pub-id>
        </citation>
      </ref>
      <ref id="B29-molbank-2015-M842">
        <label>29.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Lipton</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Mauragis</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Veley</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Bundy</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Banitt</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Dobrowolski</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Four Generations of Pyrrolopyrimidines</article-title>
          <source>From Bench to Pilot Plant</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Nafissi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ragan</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>DeVries</surname>
              <given-names>K.M.</given-names>
            </name>
          </person-group>
          <publisher-name>American Chemical Society</publisher-name>
          <publisher-loc>Washington, DC, USA</publisher-loc>
          <year>2002</year>
          <fpage>101</fpage>
          <lpage>112</lpage>
        </citation>
      </ref>
      <ref id="B30-molbank-2015-M842">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xE1;lvez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Microwave-assisted and iodine mediated synthesis of 5-n-alkyl-cycloalkane[<italic>d</italic>]-pyrazolo[3,4-<italic>b</italic>]pyridines from 5-aminopyrazoles and cyclic ketones</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2014</year>
          <volume>55</volume>
          <fpage>1998</fpage>
          <lpage>2002</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2014.02.015</pub-id>
        </citation>
      </ref>
      <ref id="B31-molbank-2015-M842">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bueno</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ortiz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Microwave induced three-component synthesis and antimycobacterial activity of benzopyrazolo[3,4-<italic>b</italic>]quinolindiones</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2014</year>
          <volume>74</volume>
          <fpage>216</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2013.12.037</pub-id>
          <pub-id pub-id-type="pmid">24463437</pub-id>
        </citation>
      </ref>
      <ref id="B32-molbank-2015-M842">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Becerra</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of Novel Pyrimido[4,5-<italic>b</italic>]quinolin-4-ones with Potential Antitumor Activity</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>2013</year>
          <volume>50</volume>
          <fpage>506</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.1510</pub-id>
        </citation>
      </ref>
      <ref id="B33-molbank-2015-M842">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Becerra</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Microwave-assisted synthesis of pyrimido[4,5-<italic>b</italic>][1,6]naphthyridin-4(3<italic>H</italic>)-ones with potential antitumor activity</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2013</year>
          <volume>60</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2012.11.037</pub-id>
          <pub-id pub-id-type="pmid">23279862</pub-id>
        </citation>
      </ref>
      <ref id="B34-molbank-2015-M842">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Portillo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>G&#xE1;lvez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Abonia</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>An efficient synthesis of pyrazolo[3,4-<italic>b</italic>]pyridine-4-spiroindolinones by a three-component reaction of 5-aminopyrazoles, isatin, and cyclic &#x3B2;-diketones</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2011</year>
          <volume>52</volume>
          <fpage>2664</fpage>
          <lpage>2666</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2011.03.067</pub-id>
        </citation>
      </ref>
      <ref id="B35-molbank-2015-M842">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Trilleras</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pantoja</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Abon&#xED;a</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Microwave-assisted synthesis of pyrazolo[3,4-<italic>b</italic>]pyridine-spirocycloalkanediones by three-component reaction of 5-aminopyrazole derivatives, paraformaldehyde and cyclic &#x3B2;-diketones</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>4717</fpage>
          <lpage>4719</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2010.07.009</pub-id>
        </citation>
      </ref>
      <ref id="B36-molbank-2015-M842">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quiroga</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Trilleras</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Insuasty</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Abon&#xED;a</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nogueras</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Marchal</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>A straightforward synthesis of pyrimido[4,5-<italic>b</italic>]quinoline derivatives assisted by microwave irradiation</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>1107</fpage>
          <lpage>1109</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2009.12.114</pub-id>
        </citation>
      </ref>
      <ref id="B37-molbank-2015-M842">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sridharan</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Mene</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Cerium (IV) Ammonium Nitrate as a Catalyst in Organic Synthesis</article-title>
          <source>Chem. Rev.</source>
          <year>2010</year>
          <volume>110</volume>
          <fpage>3805</fpage>
          <lpage>3849</lpage>
          <pub-id pub-id-type="doi">10.1021/cr100004p</pub-id>
          <pub-id pub-id-type="pmid">20359233</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Schemes</title>
      <fig id="molbank-2015-M842-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2015-M842-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of 6-(4-amino-1-methyl-2-(methylthio)-6-oxo-1,6-dihydropyrimidin-5-yl)-3,6-dimethyl-2-(methylthio)-6,7-dihydro-3<italic>H</italic>-pyrrolo[2,3-<italic>d</italic>]pyrimidine-4,5-dione.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M842-sch001.tif"/>
      </fig>
      <fig id="molbank-2015-M842-sch002" position="float">
        <object-id pub-id-type="pii">molbank-2015-M842-sch002_Scheme 2</object-id>
        <label>Scheme 2</label>
        <caption>
          <p>Plausible mechanism for the formation of the new pyrrolo[2,3-<italic>d</italic>]pyrimidine.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M842-sch002.tif"/>
      </fig>
    </sec>
  </back>
</article>
